Prognostic Evaluation of Tumor-Stroma Ratio in Patients with Early Stage Cervical Adenocarcinoma Treated by Surgery
Authors:
- Surapan KhunamornpongSKSurapan Khunamornpong
- Jongkolnee SettakornJSJongkolnee Settakorn
- Kornkanok SukpanKSKornkanok Sukpan
- Prapaporn SuprasertPSPrapaporn Suprasert
- Suthida IntaraphetSISuthida Intaraphet
- Sumalee SiriaunkgulSSSumalee Siriaunkgul
Open Access
- 3 June 2015
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (10) , 4363-4368
Abstract
The tumor-stroma ratio (TSR) represents the percentage of neoplastic cell components compared to the combined area of neoplastic cells and the surrounding tumor-induced stroma. A low TSR (predomination of stromal component) has been demonstrated to be an independent adverse prognostic factor in cancers of several organs. In cervical carcinoma patients, TSR has been evaluated in only one previous study with different histological types. The present study aimed to assess the prognostic value of TSR in early stage cervical cancer patients with adenocarcinoma histology only. Histological slides of patients with early stage (IB-IIA) cervical adenocarcinoma who underwent surgical treatment between January 2003 and December 2011 were reviewed. Patients who had received preoperative chemotherapy were excluded. TSR was categorized as low (<50%) and high (≥50%). Correlations between TSR and clinicopathological variables were evaluated. Prognostic values of TSR and other variables were estimated using Cox's regression. Of 131 patients; 38 (29.0%) had low TSR and 93 (71.0%) had high TSR. The patients with low TSR had significantly higher proportions of deep cervical stromal invasion (outer third of wall, p=0.011; residual stroma less than 3 mm, p=0.008) and parametrial involvement (p=0.026). Compared to the patients with high TSR, those with low TSR tended to have lower 5-year disease-free survival rate (83.8% versus 88.9%) and overall survival rate (85.6% versus 90.3%), although the differences were not statistically significant. Low TSR was significantly associated with decreased overall survival in univariate analysis (HR 2.7; 95% CI 1.0-7.0; p=0.041), but not in multivariate analysis. TSR was not significantly associated with decreased disease-free survival. Low TSR is associated with decreased overall survival in patients with early stage cervical adenocarcinoma treated by surgery. However, it was not found to be an independent prognostic predictor in this study.Keywords
This publication has 25 references indexed in Scilit:
- Locoregional Spread and Survival of Stage IIA1 versus Stage IIA2 Cervical CancerAsian Pacific Journal of Cancer Prevention, 2014
- Invasive Endocervical AdenocarcinomaInternational Journal of Gynecological Pathology, 2013
- Prognostic Impact of Histology in Patients with Cervical Squamous Cell Carcinoma, Adenocarcinoma and Small Cell Neuroendocrine CarcinomaAsian Pacific Journal of Cancer Prevention, 2013
- Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)Breast Cancer Research and Treatment, 2013
- Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomyJournal of Gynecologic Oncology, 2013
- Prognostic model for survival in patients with early stage cervical cancerCancer, 2010
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patientsBreast Cancer Research and Treatment, 2010
- Adenocarcinoma: A unique cervical cancerGynecologic Oncology, 2010
- Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavityHead & Neck, 2009
- Role of tissue stroma in cancer cell invasionThe Journal of Pathology, 2003